Everus 10-Q: Q3 Revenue Up 40% to $1.38B, Backlog Jumps to $4.78B
ECG is trading near its 52-week low of $70.44 (8.7% above the low) on elevated volume (2.9× avg).
Summary
Everus' Q3 10-Q confirms 40% revenue growth to $1.38 billion and $1.79 diluted EPS, but $1.21 of that EPS came from favorable catch-up estimates on prior contracts. Backlog rose to $4.78 billion, and debt increased to fund the $295 million Epsilon acquisition.
Key Events · Earnings and Guidance · ECG
-
Q3 Revenue Jumps 40% to $1.38B
Operating revenues rose 40.3% to $1,384.2 million from $986.8 million, with E&M up 48.0% on data center and high-tech work and T&D up 14.4%.
-
Two-Thirds of EPS Is Estimate Catch-Up
Changes in estimates on prior-period contracts added $82.1 million of revenue and $1.21 of diluted EPS in Q3; reported diluted EPS was $1.79.
-
Backlog Climbs to $4.78B
Remaining performance obligations reached $4.78 billion at September 30, 2026 versus $2.80 billion at December 31, 2025, including $635.3 million from 2026 acquisitions.
-
Debt Raised to Fund Epsilon Deal
The September 1, 2026 credit amendment lifted the term loan to $477.5 million and the revolver to $350.0 million ($100.0 million drawn), funding the $295 million Epsilon acquisition; total debt was $566.3 million against $264.2 million of cash.
Analysis · ECG · Real Estate & Construction
The headline numbers were already out on November 3, but the full 10-Q reveals how much of the profit is estimate-driven: $82.1 million of the quarter's revenue and $1.21 of the $1.79 diluted EPS came from upward revisions on prior-period contracts, meaning roughly two-thirds of Q3 EPS is catch-up rather than current-period work. Backlog of $4.78 billion, up from $2.80 billion at year-end (including $635.3 million from acquisitions), supports the demand story in data centers and high tech. To fund the $295 million Epsilon deal, the September 1 credit amendment added $200 million to the term loan (now $477.5 million) and $125 million to the revolver (now $350 million, with $100 million drawn), lifting total debt to $566.3 million against $264.2 million of cash. Leverage remains comfortable under the 3.00x covenant, but the earnings quality and the acquisition-funded debt load are the two things a holder needs to weigh.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ECG was trading at $76.60 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $70.44 to $171.58. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.